{"id":6712,"date":"2022-12-21T17:40:00","date_gmt":"2022-12-21T17:40:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/"},"modified":"2022-12-21T17:40:00","modified_gmt":"2022-12-21T17:40:00","slug":"inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/","title":{"rendered":"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022"},"content":{"rendered":"
\n

Nanexa AB (publ) kommenterar, den 22 december 2022, med anledning av nyhetssl\u00e4ppet den 21 december 2022, och bjuder in till en direkts\u00e4nd kommentar.<\/strong><\/p>\n<\/div>\n

\n

En direkts\u00e4nd kommentar med styrelseordf\u00f6rande G\u00f6ran Ando, vd David Westberg samt Director of Business Development Otto Skolling h\u00e5lls den 22 december kl 10:00 via Infront Direkt Studios och tittarna ges m\u00f6jlighet att st\u00e4lla fr\u00e5gor via chat.<\/p>\n

Kommentaren kommer att finnas tillg\u00e4nglig h\u00e4r<\/a>.
Kommentaren kommer \u00e4ven att l\u00e4ggas upp p\u00e5 Nanexas hemsida i efterhand.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa AB (publ) kommenterar, den 22 december 2022, med anledning av nyhetssl\u00e4ppet den 21 december 2022, och bjuder in till en direkts\u00e4nd kommentar.<\/p>\n","protected":false},"template":"","class_list":["post-6712","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nInbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB (publ) kommenterar, den 22 december 2022, med anledning av nyhetssl\u00e4ppet den 21 december 2022, och bjuder in till en direkts\u00e4nd kommentar.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\\\/\",\"name\":\"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2022-12-21T17:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/","og_locale":"sv_SE","og_type":"article","og_title":"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB","og_description":"Nanexa AB (publ) kommenterar, den 22 december 2022, med anledning av nyhetssl\u00e4ppet den 21 december 2022, och bjuder in till en direkts\u00e4nd kommentar.","og_url":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/","url":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/","name":"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022 - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2022-12-21T17:40:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/inbjudan-till-nyhetskommentar-med-anledning-av-nanexas-nyhetsslapp-den-21-december-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Inbjudan till nyhetskommentar med anledning av Nanexas nyhetssl\u00e4pp den 21 december 2022"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/6712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}